Related Experiment Video
Updated: Sep 28, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Diagnosis of Multisystem Inflammatory Syndrome in Children in a Resource-Limited Center
Nishanth Sekar1, Mayurathan Pakkiyaretnam1, Vaithehi Francis2
1Faculty of Health Care Sciences, Teaching Hospital Batticaloa, Batticaloa, LKA.
Insights
Multisystem inflammatory syndrome in children (MIS-C) is a serious condition following COVID-19 infection. Early diagnosis and management are crucial due to potential severe, multi-organ consequences.
Area of Science:
- Pediatric infectious diseases
- Cardiovascular pathology
- Immunology
Background:
- The rise of COVID-19 has been associated with the emergence of Multisystem Inflammatory Syndrome in Children (MIS-C).
- MIS-C presents a significant post-infectious complication, particularly affecting pediatric populations.
- Understanding MIS-C is critical for public health following the COVID-19 pandemic.
Observation:
- MIS-C involves multiple organ systems, including the gastrointestinal tract, kidneys, heart, and lungs.
- Key clinical indicators for suspecting MIS-C include mucocutaneous findings (conjunctival injection, red lips), neurocognitive symptoms, swollen hands, and lymphadenopathy.
- Promptly excluding MIS-C is vital when these symptoms are present in children.
Findings:
- The syndrome's manifestations are diverse and depend on the specific organs affected.
- Early and accurate diagnosis of MIS-C is paramount for effective patient outcomes.
- Various therapeutic strategies are being explored and implemented for MIS-C management.
Implications:
- Timely diagnosis of MIS-C can mitigate severe, potentially life-threatening complications.
- Recognizing MIS-C symptoms aids in appropriate and timely medical intervention.
- Further research into MIS-C pathogenesis and treatment is essential for improving pediatric care.
Abstract:
Multisystem inflammatory syndrome in children (MIS-C) has become a serious disease entity following the high prevalence of coronavirus disease 2019 (COVID-19) infection with the involvement of gastrointestinal organs, kidneys, heart, and lungs. When the patient presents with mucocutaneous findings such as conjunctival injection, red lips, neurocognitive symptoms, swollen hands and lymphadenopathy, it is always highly recommended to exclude multisystem inflammatory syndrome. As it affects multiple organs, it can result in more serious consequences. The manifestations depend largely on the organ involved. Therefore, successful management partly depends on the early diagnosis. Many treatment strategies have been put forth to tackle the disorder so far.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

